Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TCI Biotecnologia is a Brazilian biotechnology company based in Mirabela, Minas Gerais, that specializes in the research and development of advanced dermocosmetic and healthcare products. The company is recognized for its innovative Extraya antiseptic lotion and the Hycos product line, which are designed for the humanized treatment of acute and chronic skin lesions, including diabetic and vascular ulcers. TCI Biotecnologia utilizes natural actives and biotechnological processes to create high-efficacy, non-toxic formulations that promote skin repair and protection. The company collaborates with academic institutions and healthcare professionals to validate its products through scientific research and clinical trials, such as its ongoing evaluations for psoriasis treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TCI Biotecnologia.